Application of Next-Generation Sequencing in Clinical Virology

Dear Colleagues,

Next-generation sequencing (NGS) is a new technology that can be used for broad detection of infectious pathogens and is rapidly becoming an essential platform in clinical laboratories. NGS provides an effective, unbiased way to identify known as well as emerging vial pathogens without prior knowledge of pathogens. Since the COVID-19 pandemic, NGS has rapidly become an important tool for SARS-CoV-2 genomic surveillance to detect novel variants and monitor trends in circulating variants, such as the Alpha (B.1.1.7), Beta (B.1.351), Gamma (P1), Delta (B.1.617.2) and Omicron (B.1.1.529) variants. NGS continues to provide public health officials, vaccine and drug developers, and researchers with critical information in prevention, intervention, and therapeutics. Given the huge impact of NGS in clinical virology, a Special Issue of the journal Genes is being issued to explore various applications of next-generation sequencing in clinical virology. Authors are encouraged to submit original manuscripts describing utilization of NGS in clinical virology. Also encouraged are research papers describing new sequencing methodologies or instruments, and reviews or comparison studies of various NGS methods, as well as manuscripts dealing with bioinformatic methods of analysis.

Prof. Dr. Jiguo Chen
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Genes is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.